-
1
The combination of a tyrosine kinase inhibitor and blinatumomab in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia or Philadelphia chromosome‐like acute...
Published 2024-09-01Subjects: “…Philadelphia chromosome‐positive acute lymphoblastic leukemia…”
Get full text
Article